Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01224548 · ClinicalTrials.gov registry record · NA
Multicenter Worksite Nutrition Study
A NA study of Diabetes and Overweight, sponsored by Physicians Committee for Responsible Medicine.
- Completed
- Registry status
- NA
- Development phase
- 292
- Enrollment target
- 10
- Study locations
NCT01224548: Completed NA study of Diabetes and Overweight, sponsored by Physicians Committee for Responsible Medicine.
NCT01224548 is a NA study of Diabetes and Overweight that has completed, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 292 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (90% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01224548, a NA study of Diabetes and Overweight, has completed, sponsored by Physicians Committee for Responsible Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 292 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to study the potential benefits of low fat vegan diet in a randomized, controlled and multi-centered workplace setting, the investigators will enroll participants from 10 worksites of Government Employee Insurance Company (GEICO). After randomization, 5 will be the vegan sites and 5 will be the control sites for 10 month study. The vegan sites will receive low fat vegan diet instructions and weekly group sessions starting from year 1. no intervention is done to the control sites until the week 18 when the identical program will be given. At various time points, health measurements will be give to all participants.
Primary Outcome
body weight at baseline
Conditions Studied
Interventions
- OTHER control
- OTHER vegan instruction and food accessibility
Study Locations (10)
New York
- Buffalo - Buffalo
- Woodbury - Woodbury
Virginia
- Fredericksburg - Fredericksburg
- Virginia Beach - Virginia Beach
Arizona
- Tucson - Tucson
California
- San Diego - San Diego
Florida
- Lakeland - Lakeland
Georgia
- Macon - Macon
Maryland
- Chevy Chase - Chevy Chase
Texas
- Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01224548 record still lists
NCT01224548 is an interventional study that assigns participants to a tested intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.
NCT01224548 lists 10 locations in 8 states (New York, Virginia, Arizona).
Frequently Asked Questions
What is clinical trial NCT01224548 about?
NCT01224548 is a clinical study titled "Multicenter Worksite Nutrition Study". The purpose of this study is to study the potential benefits of low fat vegan diet in a randomized, controlled and multi-centered workplace setting, the investigators will enroll participants from 10 worksites of Government Employee Insurance Company (GEICO). After randomization, 5 will be the vegan...
What is the current status of trial NCT01224548?
This trial is currently completed. It is a NA study. The enrollment target is 292 participants. The study started on 2010-10. Estimated completion is 2011-10.
What conditions does trial NCT01224548 study?
This clinical trial studies the following conditions: Diabetes, Overweight.
What interventions are being tested in trial NCT01224548?
The interventions under investigation include: control (OTHER), vegan instruction and food accessibility (OTHER).
Who is sponsoring clinical trial NCT01224548?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01224548 being conducted?
This trial has 10 study locations across Arizona, California, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01224548's enrollment target sits among peer trials
292 118th of 338 higher than 221 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- NCT05406622 · 292 participants · NA
MOTIV BTK Randomized Controlled Trial
- NCT05757102 · 292 participants · Phase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- NCT06569667 · 292 participants · NA
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia